{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-079601","form_type":"8-K","ticker":"GANX","cik":"0001819411","company_name":"Gain Therapeutics, Inc.","filed_at":"2024-07-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.654598+00:00","generated_at":"2026-05-31T21:12:52.416252+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Gain Therapeutics receives Nasdaq MVLS deficiency notice; must regain compliance by Jan 7, 2025","bullets":["Nasdaq notified Gain on June 11, 2024, that MVLS was below $50M minimum required for Global Market listing.","Company has 180 days (through Jan 7, 2025) to achieve MVLS >= $50M for ten consecutive business days.","Failure to comply may lead to delisting; company could appeal or apply to transfer to Nasdaq Capital Market.","Gain intends to monitor and take reasonable measures but cannot assure compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-079601","json":"https://secwatch.observer/filing/0001104659-24-079601.json","markdown":"https://secwatch.observer/filing/0001104659-24-079601.md","text":"https://secwatch.observer/filing/0001104659-24-079601.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819411/000110465924079601/0001104659-24-079601-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819411/000110465924079601/tm2419326d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T21:12:52.416252+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}